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Abstract 
 
Principal Component analysis (PCA) is a useful statistical technique that is commonly used for multivariate 
analysis of correlated variables. It is usually applied as a dimension reduction method: the top principal 
components (PCs) explaining most of total variance are tested for association with a predictor of interest, and 
the remaining PCs are ignored. This strategy has been widely applied in genetic epidemiology, however some 
of its aspects are not well appreciated in the context of single nucleotide polymorphisms (SNPs) association 
testing. In this study, we review the theoretical basis of PCA and its behavior when testing for association 
between a SNP and two correlated traits under various scenarios. We then evaluate with simulations the 
power of several different PCA-based strategies when analyzing up to 100 correlated traits. We show that 
contrary to widespread practice that testing the top PCs only can be dramatically underpowered since PCs 
explaining a low amount of the total phenotypic variance can harbor substantial genetic associations. 
Furthermore, we demonstrate that PC-based strategies that use all PCs have great potential to detect 
negatively pleiotropic genetic variants (e.g. variants with opposite effects on positively correlated traits) and 
genetic variants that are exclusively associated with a single trait, but only achieve a moderate gain in power 
to detect positive pleiotropic genetic loci. Finally, the genome-wide association study of five correlated 
coagulation traits in 685 subjects from the MARTHA study confirms these results. The joint analysis of the five 
PCs from the coagulation traits identified two new candidate SNPs, which were most strongly associated with 
the 5th PC that explained the smallest amount of phenotypic variance.  
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Introduction 
 
Common diseases such as asthma or type-2 diabetes are often studied through related phenotypes. 
The identification of genetic variants that influence these correlated, and potentially intermediate, 
phenotypes may hold the key to understanding the genetic architecture of the disease in question. While 
many studies analyze each of these phenotypes separately, their joint analysis is likely to have increased 
statistical power in many instances[1]. However, integrating association signals observed between a single 
SNP and multiple traits in a single comprehensive framework is not always straightforward. Simple 
approaches, such as Fisher’s method applied to univariate analysis of each phenotype can yield inflated type I 
error rate when the traits are correlated. More complex methods can indeed be applied. For example, mixed 
models have been proposed recently for modeling the covariance structure caused by correlated phenotypes 
as well as population structure [2,3], but this approach quickly becomes computationally intractable as the  
number of phenotypes grows.  Several other sophisticated approaches for jointly analyzing correlated traits 
exist, but their respective advantages and limitations are generally not well understood. Many of them are 
related to canonical correlation analysis (CCA) [4,5], and consist in identifying the linear combination of a set 
of variables that is the most highly correlated with any linear combination of a second set of variables 
(equivalent to a one-way MANOVA when analyzing a single SNP). A slightly different strategy, also related to 
CCA, consists in focusing first on the core structure of the data by extracting the shared and specific parts of 
the original phenotypes. The guiding principle here is to build new variates using spectral decomposition of 
either the covariance or correlation of the original phenotypes, as done in principal component analysis 
(PCA), so that these new variates, or components, are uncorrelated from each other and explain successively 
maximum variance. There are two major advantages in applying such a technique. First, because all 
components are independents, their multivariate analysis is straightforward. Second, since most of the 
phenotypic variance is usually captured by the first few components, this approach can be used as a variable 
reduction method. 
In this study we focus on PCA-based strategies for multivariate analysis of multiple traits, a common 
application in genetic epidemiology that has been proposed for linkage analysis (e.g. [6]) and genome-wide 
association studies (GWAS)[7-13]. For the purpose of GWAS, and following the principle of dimension 
reduction, one typically tests for an association between each SNP and the first few principal components 
(PCs) that explain most of the total phenotypic variance. For example, in a recent GWAS of facial morphology, 
researchers used the first 11 PCs from the facial shape phenotypes, each explaining at least 1% of the total 
phenotypic variance [7]. In another recent GWAS of metabolic syndrome traits, PCA was applied 
independently on 6 domains, including a total of 19 phenotypes. In this study the few first principal 
components were extracted for each domain so that they explained at least 55% of the total phenotypic 
variance [8]. Downstream from selecting the top PCs, various different analysis strategies have been applied 
in the literature. In many studies these top PCs were analyzed individually (univariate analysis) and their 
loadings (i.e. the weight of each raw phenotypes, e.g. [9-12]) were reported. Other studies either conducted 
standard multivariate analysis of these components, e.g. [8]) or built more complex combined tests that 
accounted for other sources of information [13]. 
Overall, previous work has clearly demonstrated the utility of PCA-based GWAS strategies that focus on 
the top principal components. However questions remain about which PCA strategy is the most powerful for 
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detecting associations, how to interpret signal observed on PCs, and under what conditions are PCA-based 
multivariate analysis expected to outperform a simple univariate analysis of the raw phenotypes. The aim of 
this study is to address these questions both analytically and using simulations. Unlike previous studies that 
assume and model complex associations between the SNP and the traits studied [14] or discuss causal 
inference [1], this study explores the use of PCA for performing GWAS in multiple correlated phenotypes 
simultaneously without making any strong assumption about the underlying model. First, we review some of 
the theoretical basis for PCA and describe the expected behaviors of univariate analysis of each PC when 
analyzing two correlated phenotypes. We then explore the power of various PCA-based strategies when 
analyzing a larger number of simulated correlated phenotypes. We show, contrary to the current prevalent 
belief, and as previously discussed for the analysis of non-genetic data (e.g. [15]), that principal components 
explaining a small amount of total phenotypic variance can be as important as those explaining large amount 
of variance. In many scenarios these components capture a large proportion of the genetic effect. Discarding 
these lower-variance PCs can, therefore, severely decrease power to detect genetic variants associated with 
one or more of the traits. Finally, we confirmed the usefulness of these results by analyzing 5 coagulation 
related quantitative traits in 685 subjects from the MARTHA study [16,17]. 
 
 
Material and Methods 
 
Analysis of two phenotypes 
For illustration, consider a hypothetical model where two positively correlated and normally distributed 
phenotypes, Y1 and Y2 with mean 0 and variance 1 both depend on an unknown variable U and a scaled 
genotype G, that are also normally distributed with mean 0 and variance 1. Let c denote the correlation 
between Y1 and Y2 due to U and v1 and v2 the proportion of variance of Y1 and Y2 explained by G, respectively. 
We assume the effects of U and G on Y1 and Y2 are positive and, (c+vmax), where vmax is the maximum of v1 and 
v2, can vary in [0, 1], so that the two traits can be expressed as: 
 
   √    √     √            (A)    
   √    √     √              (B), 
 
where 1 and 2 denote independent random noises that are normally distributed with mean 0 and variance 
1. The principal components of these two traits are     
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The total phenotypic variance explained by pc1 and pc2, and noted respectively by s1 and s2, can be defined as 
(see text S1): 
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From this it follows that vpc1 and vpc2, the proportion of variance of pc1 and pc2 explained by G can be 
respectively expressed as (see text S1): 
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The power of the association tests between G and, Y1, Y2, PC1 and PC2 can then be compared for 
different sample size and genetic effect. If N is the sample size, the Wald test for association, equal to    ̂  
where  ̂  is the estimated proportion of variance explained by G, follows a non-central chi-square with one 
degree of freedom (df) and non-central parameter equal to       , so the power equal [18]: 
 
         (        
 |   )           
 
where     |     is the cumulative probability function of the non-central chi-square distribution with d 
degrees of freedom and non-centrality parameter  ;      
  is the inverse of F, i.e. the quantiles of the non-
central chi-square distribution, and  is the type I error rate. Since the two PCs are independents, one can 
also define a joint test of the PCs by summing the 1df non-central chi-square from each PC to form a 2df non-
central chi-square. The power for such a test is equal to: 
 
         (        
 |   )            
 
For simplicity, we derived the proportion of variance explained and the power to detect the effect of a 
genetic variant under the assumption that the effect of the unknown source of correlation, U, and the genetic 
effects on the traits were all positive (and so in the same direction). All other patterns where the genetic 
effects are consistent with the correlation (e.g. negative correlation and genetic effect in opposite direction 
on the two traits) produce the exact same results. The extension to the situation where the genetic effect is 
opposite to the correlation is straightforward. 
 
Analysis of five correlated phenotypes 
We simulated four series of 10,000 dataset of 5,000 subjects, each series corresponding to a given 
model of correlation pattern. For each subject we generated a SNP G with minor allele frequency of 0.3 and 
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five phenotypes Y1 to Y5. The phenotypes were generated as defined in equation (A), and c was defined so 
that the average correlation pattern between the Ys match the following correlation matrices: 
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When genetic effect on a trait was simulated, the proportion of variance in that trait explained by G was 
drawn from a uniform distribution with minimum 0.001 and maximum 0.005, independently to phenotypic 
correlation. When pleiotropic effects were generated, the K=2,..,5 phenotypes affected by the SNP were 
randomly chosen (with equal probability). However, we also simulated situations where the pleiotropic effect 
of the SNP reflects the phenotypic correlation pattern, that is, assuming that the most highly correlated traits 
are more likely to be associated with the same genetic variants. To do so, we assigned the probability that 
the ith phenotype was associated with G to be proportional to its correlation with other traits. For example in 
the presence of a pleiotropic effect on two phenotypes under model 2, the two traits Y1 and Y2, correlated at 
0.8, had much higher chances to be selected. Note that this modification does not affect the simulations 
results based on model 3 and model 4, since all phenotypes are equally correlated to the others. 
 
Combined analysis of venous thrombosis related phenotypes 
Five quantitative intermediate phenotypes for venous thrombosis risk measured in the MARTHA 
study were analyzed in this report for illustrative purposes. MARTHA individuals are unrelated Europeans 
patients with venous thromboembolism, consecutively recruited at the Thrombophilia center of La Timone 
Hospital (Marseille, France) between January 1994 and October 2005. All subjects were typed for genome-
wide single nucleotide polymorphisms (SNPs) using the Illumina Human610-Quad and Human660W-Quad 
Beadchips. Five coagulation related phenotypes were studied: three plasma levels of coagulation factors, 
Fibrinogen (FIB) factor VIII (FVIII), and von Willebrand factor (vWF); the activated partial thromboplastin time 
(aPTT) and the standardized Anticoagulant response to Agkistrodon contortrix venom (ACVn). These 
phenotypes have already been analyzed under a GWAS framework using either raw genotypes or imputed 
SNPs according to HapMap 2 database. A detailed description of the cohort and the phenotypes can be found 
in [16,17,19]. In the current application, we further conducted an imputation analysis based on the 1000 
Genome 2012-02 release using the minimac software (release 2012-03-14). SNPs with imputation quality 
Rsq>0.3 and minor allele frequency (MAF) >0.01 (N = 8,862,493) were used in this study. Imputed SNPs were 
tested for association with the raw phenotypes and the derived PCs using a linear regression analysis in which 
allele dosage of imputed SNPs was used. For this, we employed the mach2qtl software [20]. These 
association analyses were conducted in a sample of 685 patients with no missing phenotype information and 
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were adjusted for age, sex, anti-coagulant therapy, smoking and the four first principal components derived 
from the genome-wide genotype data to handle any undetected population stratification. 
 
 
Results 
 
Comparison of power for the analysis of two phenotypes 
Let us first consider the analysis of two correlated traits y1 and y2 (equation (A) and (B)) where the 
tested SNP only has an effect on y1. When the genetic effect is small, so that the contribution of the SNP in 
the correlation between the two traits is negligible, the two PCs (equation (C) and (D)) can be approximated 
by: 
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where   
  are normal N(0,1) variables. The proportion of the total variance explained by PC1 and PC2 
(equation (E) and (F)) simplifies to           ⁄  and           ⁄  respectively, so that these two 
proportions only depend linearly on c, the correlation between the two traits. Hence, s1 becomes 
approximately equal to s2 when c is small, but larger than s2 when c increases. 
From equation (K) and (L) we can see that PC1, although it depends slightly on G, captures essentially 
the effect of U, the unmeasured variable representing the shared effect. Conversely the effect of U is, by 
construction in this example, not captured by PC2, which depends only on the effect of the SNP on Y1 plus 
some residual noise. This noise scales with the phenotypic correlation, decreasing dramatically with 
increasing value of c. This makes PC2 the most relevant component to capture a genetic variant that affect 
only a single phenotype. However, as noted above, for moderate correlation, G has a non-negligible effect on 
both PCs, so that combining the results from the two components might be a relevant alternative to the test 
of PC2 only. Figure 1 presents a comparison of the power for the test of association between G and 
respectively PC1, PC2 and the combined PCs, against the test of association between G and Y1 when the SNP is 
associated with Y1 and but not with Y2. In this case the combined PCs test and the test of PC2 has greater 
power than the test of Y1 when the correlation is large, but lower power when correlation is low. This gain in 
power tends to be larger for the combined PCs as compared to PC2 when the effect of G on the trait is large, 
or when the sample size increases (Figure 1A). Conversely, the test of PC2 becomes optimal when sample size 
or genetic effect is small, and correlation is larger than 0.5 (Figure 1B). 
When the tested SNP affects both traits, one can similarly derive the power for each of the three 
previous tests against the test of Y1 and Y2. Figure 2 present such results for correlation c equal to 0.1, 0.5 and 
0.9, while assuming G explains 0.5% of the variance of Y1 and between 0 to 1% of the variance of Y2. 
Furthermore, we considered the directionality of the SNP effects for the second trait: the same direction as 
on the first trait (positive pleiotropy), and effects in opposite directions on the two traits (negative 
pleiotropy). Similarly to the previous scenario, the proportion of the total variance explained by PC1 increases 
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with c, but conversely PC1 displays most of the genetic effect if G has similar effects on both of the traits (i.e. 
is in same direction). This can be explained by considering vpc1 and vpc2, the proportion of variance explained 
by G on the PCs (equation (G) and (H)). For example, when v1 = v2 = v’, vpc2 is null and vpc1 can be 
approximated by          ⁄ . Since c is by definition smaller than 1, the test of PC1 in this specific case will 
always outperform the test of each trait independently and the test of PC2. When the genetic effects are in 
opposite directions (negative pleiotropy), large gains in power can be achieved by testing for PC2, while 
testing for PC1 has almost no power. This is consistent with the results of Korte et al. 2012 [2], where they 
reported increased power to detect trait specific and negative pleiotropic genetic effects when accounting for 
the correlation between the traits. In this case, the effect of G on PC2 can be approximated by          ⁄ , 
so that the effect of G increases exponentially with increase in c. Although the expected power of the 
combined PCs analysis in all these situations is usually lower than the power of single PCs when assuming a 
specific direction of genetic effect on the traits, it offers a good compromise, allowing for reasonable power 
without assuming specific hypothesis about the genetic effect. A summary of how the different tests based 
on PC1, PC2, and the combined test of the two PCs behave for moderate sample size, is shown in Table 1. 
 
Comparison of power for the analysis of five phenotypes 
When more than two phenotypes are considered, deriving the power of the various analysis 
strategies quickly becomes too complex to be comprehensively expressed since it depends on many factors, 
including the correlation pattern between the phenotypes and the magnitude and direction of effect of the 
tested SNP on each phenotype. To explore the power of univariate and multivariate tests in these situation 
we simulated data for five phenotypes, Y1 to Y5, under various scenarios and we estimated the power of four 
strategies: the univariate test of the original phenotypes, the univariate test of each PC, the test of the PC 
displaying the largest genetic effect after correcting for multiple testing, and the combined test of all PCs. We 
considered four correlation models across the phenotypes analyzed: 1) a gradient of moderate to low 
correlations, 2) a gradient of strong to low correlations, 3) a uniform moderate correlations and 4) a uniform 
strong correlations (see Methods). For each model we studied first situations where the genetic variant is 
associated with a single trait (Figure 3), and then situations where the genetic variant has a pleiotropic effect 
(Figure 4). 
Generally, no single PC was optimal to detect the associated SNP over all scenarios considered. The 
association pattern between the SNP and the five components varied greatly across the set of parameters we 
used. Sometimes the strongest association was with the PCs explaining most of the variance (e.g. when the 
genetic effect is associated with the 5 traits and the correlation between the trait is smaller than 0.5); 
sometimes the strongest association was with the PCs explaining the smallest amount of the total variance 
(e.g. when the SNP is associated with several, but not all traits, and there is correlation >0.5 among all traits). 
Hence, in most situations, the strategy of testing all PCs and picking the one with the strongest signal was 
more efficient than focusing on the PCs explaining most of the variance. However, because most PCs showed 
association signals, the combined approach was on average the most powerful except when SNP had an 
effect on a single trait that had correlation lower than 0.5 with the other traits analyzed, or in the presence of 
a fully pleiotropic effect (i.e. the SNP is associated with all 5 traits) and the correlation between traits is 
homogeneous and small (<0.5). 
In all these simulations we considered situations where the genetic effect was in the same direction 
for all phenotypes and we generated pleiotropic patterns independently from the phenotypic correlation 
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patterns. As shown in Figure S1, allowing for effects in opposite directions dramatically increases the 
detection power of all three PC-based approaches (the univariate PC analysis, the combined PCs and the 
“best PC” approach). When the pleiotropic effect was generated to reflect the phenotypic correlation (the 
most highly correlated traits where more likely to be associated to the genetic variant, see Methods), the 
association patterns (Figure S2) were similar to those observed without accounting for the correlation among 
traits (Figure 4).  
 
When a very large number of phenotypes are analyzed 
The simulations in the previous section show that when a relatively small number of phenotypes are 
analyzed jointly, the genetic association signal is spread across most or all of the PCs, making the analysis of a 
single PC or the combined analysis of a sub-group of PCs less powerful as compared to the combined analysis 
of all PCs. However, when the number of phenotypes becomes very large this will not be always true, since 
the large increase in degree of freedom will balance any small association signal displayed on each PCs.  
Consider a scenario with genome-wide genetic data and a very large number of traits, say for example, 
circulating levels of a hundred metabolites. Under such a scenario, when analyzing 2000 subjects and 
assuming that the genetic effects are of the same order of magnitude as in the previous simulations (i.e. 
proportion of variance explained between 0.1% and 0.5%), the power of the univariate test of the raw 
phenotypes at genome-wide significance level (and before any correction for the hundred 100 tests 
conducted) is below 1%. Depending on the correlation pattern, and the level of pleiotropy, focusing on a sub-
group of PCs may increase or decrease power. This is demonstrated in Figure 5, where the power at 5×10-8 
significance level is shown for different tests when analyzing 100 phenotypes simulated using a gradient of 
correlation from 0 to 0.9 (extended model 2 from the previous section, but using the more complex 
simulation scheme SC1 described in supplementary text S2 and supplementary figure S3), and generating 
genetic pleiotropic effects at random, i.e. assuming genetic effects can appear on any phenotype with equal 
probability. We constructed two series of 100 tests by combining either the smallest n PCs that explain the 
least amount of the total phenotypic variance (i.e. the smallest eigenvalues), or the largest n PCs that explain 
the largest amount of the total phenotypic variance (i.e. the largest eigenvalues), with n varying from 1 to 
100. When the genetic variant affected 5 traits, we observed a substantial gain in power when focusing on 
the 10 PCs corresponding to the 10 smallest eigenvalues as compared to the combined analysis of all PCs 
(power was 0.59 and 0.23 respectively). However, using the same simulation scheme, that same test (10 PCs 
corresponding to the 10 smallest eigenvalues) was dramatically underpowered when the SNPs was 
associated with 20 traits (power was 0.63 and 0.99 respectively).  
While the optimal strategy will highly depend on the underlying model, we observed that a naïve 
approach that consists in analyzing the PCs jointly in a few sub-groups based on their eigenvalues, can 
significantly improve power. For example in figure S4 we show that combining the joint signal of a subset of 
the PCs having the highest eigenvalues with the joint signal from the remaining PCs (having the lowest 
eigenvalues) can have increased power in many hypothetical scenarios with a wide range of latent variables 
and different patterns of genetic effects (see simulation schemes SC1, SC2 and SC3 in text S2 and figure S3). 
Applying the Fisher’s method, such a test can be written as: 
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where K is the number of top PCs included in the first group, and N the total number of PCs is equal to 100. 
The   
  is the chi-square association statistic between the SNP and the ith PC, and     |   is the cumulative 
probability function of the central chi-square distribution with d degrees of freedom. Since all PCs are 
independents, TK follows a chi-square distribution with 4 degree of freedom under the null hypothesis of no 
association with any of the PC. 
 
GWAS of coagulation related phenotypes 
To illustrate the importance of including principal components that explain a small proportion of total 
phenotypic variance in the analysis we conducted a genome-wide scan of five coagulation related 
phenotypes in 685 individuals from the MARTHA study, namely fibrinogen (FIB), factor VIII (FVIII), von 
Willebrand factor (vWF), the activated partial thromboplastin time (aPTT) and the standardized anticoagulant 
response to Agkistrod on contortrix venom (ACV). All these phenotypes reflect global coagulation activity and 
display moderate to strong correlation. The correlation matrix between these traits (supplementary table S1) 
was very similar to that simulated in model 2, with a gradient of absolute value correlation varying between 
0.75 (FVIII and vWF) to 0.013 (FIB and aPTT). The five principal components extracted from the standardized 
phenotypes explained 46.22, 18.86, 18.32, 12.48 and 4.11 percent of the total phenotypic variance 
respectively. The individual trait loadings for each of the 5 PCs are presented in supplementary table S2. 
The results from the univariate analysis of each original trait and the univariate analysis of each PC 
(adjusted for multiple hypothesis testing using Bonferroni correction) compared to the multivariate analysis 
of the PCs were consistent with the conclusions drawn from the simulation study. All of the five loci that were 
found to be genome-wide significant (P<5×10-8) in a single trait analysis were also significant in the combined 
PC analysis (Table 2). Conversely, focusing for example on the top two PCs explaining more than 55% of the 
variance as done in [8] would have identified only one of these five SNPs. The combined PCs analysis 
furthermore identified two new variants, one on chromosome 18q21.2 located between two genes, DCC and 
the RPS8P3 pseudo-gene (P=1.7×10-8). This SNP was suggestive genome-significant based on the univariate 
analysis of FVIII (P=1.7×10-7 and beta coefficient of the coded allele (allele T against C) of 1.8) and slightly 
associated with vWF (P=0.035 and beta coefficient of 0.89).  The second locus found in the combined PCs 
analysis was just below the genome-wide significant level (P=5.8×10-8). It is located on chr10p11.22 lying 
between the interesting genes ITGB1 and NRP1. This SNP had a marginal effect on FVIII and vWF (the beta 
coefficients of the coded allele (allele A against G) were 0.502 and 0.297, respectively) that did not rich 
suggestive genome-wide significance (p-value of 6.6 x 10-7 and 0.0073 respectively) 
 Several patterns of association observed in the simulation study were also observed in the empirical 
data. First, the genetic signal at the most associated loci was spread out across the PCs with association 
pattern changing across loci; thus, focusing only on the univariate signal from the top PCs was suboptimal. 
Applying the combined PCs approach on the top 2 or top 3 PCs was underpowered for the same reason (data 
not showed). When the SNP only affected a single trait that was moderately correlated to the others, there 
was no gain in using PCA-based approaches (e.g. SNPs rs6025, rs710446 and rs191945075 in Table 2), 
however when the affected trait had correlation with another trait above 0.5, the combined PCs had the 
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highest power (e.g. SNPs rs576123, rs183013917 and rs76854392 in Table 2). Indeed we noted that 
association signals at new loci identified by the combined PCs analysis were driven by signal from the last PC, 
which explained 4% of the total phenotypic variance. These new signals involve non-pleiotropic effects, or at 
least unbalance genetic effect on FVIII and vWF, the most correlated traits. This confirms: 1) that PCA-based 
analysis of multiple traits can improve detection of genetic variants harboring pleiotropic effects but also 
those affecting a single trait; and 2) that PCs explaining a low amount of variance can be as important as 
those explaining large amount. 
 
 
Discussion 
 
Principal component analysis is a common tool that has been widely used for the combined analysis of 
correlated phenotypes in genetic linkage and association studies. In this study we show that PC-based 
analyses that focus on the few components explaining most of the phenotypic variance, as done in many 
studies, is generally suboptimal. By deriving the power for PC analysis in a simple case of two phenotypes and 
by conducting simulations for more complex situations, we show that a genetic association signal may in 
practice be spread across many or all of the principal components. Under many realistic scenarios important 
genetic signals, e.g. trait specific or negative pleiotropic genetic effects (e.g. positive correlation and opposite 
genetic effects), are captured by the PCs explaining the least amount of the total phenotypic variance. We 
demonstrated that combining the signal from multiple PCs, including those explaining a small amount of 
variance, is an efficient strategy for the identification of genetic variants having pleiotropic effect and those 
with no pleiotropic effect but associated with a trait that is highly correlated with the other traits in the 
study. 
Since PCs are linear combinations of the raw phenotypes, testing jointly the genetic effect on all PCs is 
asymptotically similar to applying the Fisher’s method when the traits analyzed are uncorrelated. More 
generally, it is closely related to standard multivariate approaches such as one-way MANOVA. The power of 
the joint PC test is also quite similar to that of the analytic approach implemented in the software MultiPhen, 
which applies ordinal logistic regression using the genetic variant as the outcome and the phenotypes as 
predictors [21](Figure S5). However using principal components may be easier to implement in a genome-
wide analysis context and offer more flexibility than these integrated approaches. For example, it is 
straightforward to apply alternative tests for association that capture non-linear effects to each of the PCs, 
and then combine the results of these tests across PCs using Fisher’s product test. This approach may be 
particularly useful in the presence of heterogeneous genetic effects, as in the case of gene-gene or gene-
environment interactions with an unknown (or unmeasured) effect modifier [22]. Moreover, we noticed that 
Multiphen has an inflated type I error rate when analyzing many correlated phenotypes in moderate sample 
size (e.g. 50 phenotypes in 1000 subjects), while combining the PCs remains robust at least among scenario 
we considered (Figure S6). 
Although focusing only on a few PCs is unlikely to improve statistical power when the total number of 
phenotypes analyzed jointly is small (e.g. <10), this is not necessarily the case when analyzing a very large 
number of phenotypes. When considering a more diverse range of underlying models, involving multiple 
latent variables and various patterns of genetic effects, we found that increase in power can be achieved by 
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applying a naive multistep approach, where signal on PCs are merged into sub-group based on their 
eigenvalues and the association signal across all groups tested jointly using the Fisher’s method. This strategy 
and other approaches may be worth exploring in the future. While exploring these alternative models, we 
also noticed the consistent efficiency of MANOVA that achieved close to optimal power in many instances 
(Figure S5). 
We simulated a wide range of trait correlation and pleiotropic patterns, nevertheless, no simulation 
study can be exhaustive. It is possible that analyses based on a specific mechanistic hypotheses may be more 
powerful when the mechanistic hypotheses hold. But such methods often lose power when the hypothesized 
mechanism does not hold. For example, the recently-proposed TATES statistic was shown to outperform 
MultiPhen in a range of scenarios when the genetic effect of a SNP was constant across multiple traits  (e.g. 
v1=v2 in equations (A) and (B))[14]. When we compared the performance of tests in situations where the 
genetic effects varied across traits, TATES had notably less power than other approaches, including the 
combined PCs strategy (supplementary figure S4 and S5). Although there exist situations where some tests 
may have more power, we believe the combined PC approach is an attractive approach as it retains relatively 
good power across a wide range of alternatives.  This makes the combined PC approach particularly 
appealing when the underlying mechanism is unknown. 
Finally, as for standard linear regression of the raw phenotypes, linear regression of PCs is sensitive to 
outliers and can make the test invalid. However additional simulations we conducted, showed that an 
increase in type I error rate only appears in the presence of a large number of outliers with values that are an 
order of magnitude larger than expected. Moreover, deviation from the null hypothesis would affect mostly 
genetic variants with very low frequencies (MAF<1%) and only have a small impact on common genetic 
variant (data not showed). We did not address adjustment for covariates in our simulations, however the 
regression-based context allow to add any covariates of interest using either a two steps strategy, where 
effect of covariates are regressed out at step 1 and residuals are used as outcome at step two, or by simply 
adding the covariate in the univariate test of the PCs. Since PCs are linear combination of the original 
variables, the effects of the covariates are simply projected on the PCs according to loadings of the 
phenotypes. While previous works has suggested that adding covariates in the model might be more 
powerful [23], it is equivalent to the two-step approach when the tested SNPs are not correlated with the 
covariates or interacting with the covariates [24]. 
The genetic variants identified in the MARTHA study at genome-wide significance level are mostly known 
variants. The association between the ABO gene and FVIII and vWF has been known for decades [25,26]; the 
two variants associated to aPTT (rs710446 and rs1801020) have been reported previously [19], and the two 
loci associated with ACVn, LRP4 and F5, have already been described by Oudot et al [16]. Two new variants 
were identified by the combined PCs approach at genome-wide or nearly genome-wide significance level, the 
SNP rs183013917 that is mainly associated with FVIII and the SNP rs76854392 near gene NRP1, which is 
associated to both FVIII and vWF. Although these are potential candidates, especially the NRP1 gene because 
of previous studies showing association with angiogenesis (e.g. [27]), they deserved further replication before 
being confirmed. 
A number of studies have used principal component analysis for the multivariate analysis of correlated 
phenotypes. Most of them followed the standard strategy which consists in focusing on the few top PCs 
explaining most of total variance and removing those explaining a low amount of total variance. In this work, 
we show that contrary to this widespread practice, testing the top PCs only can be dramatically 
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underpowered since PCs explaining a low amount of the total phenotypic variance can harbor a substantial 
part of the total genetic association. We also demonstrate that PCA-based strategies only achieve a moderate 
gain in power in the presence of positive pleiotropy, but have great potential to detect negative pleiotropy or 
genetic variants that are associated with a single trait highly correlated to others. 
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Figure 1. Power to detect a SNP associated with a single trait in a bivariate analysis. Power to detect the 
SNP associated with Y1 based on the tests of PC1, PC2, the combined PCs,andY1for different sample size and 
genetic effects (A and B), and proportion of variance explained by PC1 and PC2(C). The power of each of the 
four tests is presented as a function of c the correlation between Y1 and Y2, the sample size N, and v1 and v2, 
the proportion of the variance of Y1 and Y2 explained by the SNP respectively. 
15 
 
 
 
 
Figure 2. Power to detect a SNP associated with two traits in a bivariate analysis. Power at 5 x 10-
8significance level to detect the SNP associated with the Y. using the independent tests of Y1, Y2, PC1 and 
PC2and a combined PCs test when analyzing 5000 individuals. The genetic variant has a fixed effect on the 
trait Y1. The power of each of the four tests is presented as a function of the effect on the second trait Y2 for 
three level of correlation between Y1 and Y2, 0.1 (A), 0.5(B) and 0.9(C). 
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Figure 3. Power comparison for the multivariate analysis of five traits in the absence of pleiotropic effect. 
Power at 5 x 10-8 significance level for the detection of a genetic variant when analyzing five phenotypes. 
Only one phenotype is simulated as a function of the genetic variant, with proportion of variance explained 
equal to 0.5%. The bars represent the power of eight different tests. The univariate tests for each PC are 
shown in light grey and dark grey after correcting for the multiple testing, and the univariate test for the most 
significant PC (tPC) is in blue. The combined test of all five PCs is shown in black, and the univariate test for 
the associated Y in light green (dark green after correcting for the multiple testing). The power is shown for 
four different correlation models and 10,000 simulation replicates with 2000 individuals. 
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Figure 4. Power comparison for the multivariate analysis of five traits in the presence of pleiotropic effect. 
Power at 5 x 10-8 significance level for the detection of a genetic variant when analyzing five phenotypes. 
Between one and five phenotype are simulated as a function of the genetic variant, where its proportion of 
variance explained was randomly chosen between 0.1% and 0.5%. All genetic effects were positive and the 
associated phenotypes were randomly selected with equal probability. The bars represent the power of eight 
different tests. The univariate tests for each PC are shown in light grey and dark grey after correcting for the 
multiple testing, and the univariate test for the most significant PC (tPC) is in blue. The combined test of all 
five PCs is shown in black, and the univariate test for the corresponding Y in light green (dark green after 
correcting for the multiple testing). The power is shown for four different correlation models and 10,000 
simulation replicates with 2000 individuals. 
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Figure 5. Statistical power for multivariate analysis of 100 traits. Power at 5 x 10-8 significance level over 
10,000 replicates for the detection of genetic variant when analyzing jointly 100 phenotypes in 2000 
individuals. The correlations between the phenotypes were generated using 30 latent variables (see 
simulation scheme SC1 in supplement text S2 and figure S3), so that the pairwise phenotypic correlations 
follow a gradient from 0 to 0.9 (C). The red curve corresponds to the test combining the association signal 
from the first n PCs (largest eigenvalues), and the black curve corresponds to the test combining the 
association signal from the last 101-n PCs (smallest eigenvalues), with n varying from 1 to 100 and being 
equal to the rank of the PCs based on eigenvalues. The dashed grey line corresponds to the test that 
combines all PCs. Power is plotted when the genetic variant under study affect 5 phenotypes (A), 20 
phenotypes (B). Phenotypes associated with the SNP are drawn with probability proportional to their 
correlation with other traits. 
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Table 1. Rational for testing genetic association with PCs in a bivariate analysis  
Test PC1 PC2 Combined PCs 
Genetic Model    
Y1 ≠ 0 and Y2 = 0 
Almost no power, 
converging to 0 with 
increase correlation 
Most powerful for small 
sample size and lowY1. Power 
increases with correlation 
Most powerful for large sample 
size and large Y1. Power 
increases with correlation 
Y1 in the same 
direction as Y2 
Most powerful when 
correlation and Y. are 
moderate. 
Very low power. 
Power increase slightly with 
correlation 
Most powerful when 
correlation and Y. are high. 
Y2 opposite to Y1 
Almost no power. 
Minor variation with 
increase correlation 
Very powerful. 
Power increase with 
correlation 
Very powerful. 
Power increase with 
correlation 
The two traits are denoted Y1 and Y2 and, and genetic effect of G on Y1 (Y1)and Y2 (Y2) 
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Table 2. Genome-wide significant SNPs from the three approaches: univariate phenotypes, univariate PCs and combined PCs approach 
SNP id Chr Gene* MAF Rsq  P-value 
  
 
   
ACVn FIB FVIII aPTT vWF 
 
PC1 PC2 PC3 PC4 PC5 
 
combPC 
rs6025 1 F5 0.90 0.93 
 
5.3 x 10
-23
 - - - - 
 
0.21 0.0091 1.1 x 10
-17
 - - 
 
1.8 x 10
-18
 
rs710446 3 KNG1 0.54 0.99 
 
- - - 5.2x 10
-11
 - 
 
0.064 0.0083 - 8.2 x 10
-8
 - 
 
3.3 x 10
-10
 
rs1801020 5 F12 0.78 0.86 
 
0.29 0.19 - 2.2 x 10
-12
 - 
 
- 1.0 x 10
-5
 0.0057 5.8 x 10
-9
 - 
 
7.6x 10
-15
 
rs576123 9 ABO 0.55 0.86 
 
- - 2.7 x 10
-9
 9.7 x 10
-5
 1.1 x 10
-13
 
 
3.6 x 10
-10
 0.00011 - 0.0062 - 
 
1.2x 10
-14
 
rs76854392 10 NRP1 0.90 0.74  - - 6.6 x 10
-7
 - 0.0073  0.00075 - 0.029 0.28 0.00034  5.8x 10
-8
 
rs191945075 11 LRP4 0.96 0.60  2.8x 10
-25
 0.095 - - -  0.017 0.00072 1.5 x 10
-17
 - -  1.3 x 10
-19
 
rs183013917 18 DCC  0.99 0.82 
 
- - 1.7x 10
-7
 - 0.035 
 
0.0017 - - 0.12 7.0 x 10
-6
 
 
1.8 x 10
-8
 
Abbreviation: Chr, chromosome; MAF, minor allele frequency; Rsq, quality control imputation criterion ; FIB, Fibrinogen ; FVIII, factor VIII ; vWF, von Willebrand factor; aPTT, the activated 
partial thromboplastin time ;  and ACVn, the standardized Anticoagulant response to Agkistrodon contortrix venom ;  combPC, combined PCs approach 
*physically closest gene. 
The p-values for univariate raw phenotype analysis and univariate PC analysis were adjusted for multiple tests using the Bonferroni correction. P-values greater than 0.3 were replaced by 
the sign “-“. The most significant test is indicated in bold. 
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Figure S1. Power comparison for the multivariate analysis of five traits in the presence of negative 
pleiotropy. Power at 5 x 10-8 significance level for the detection of a genetic variant when analyzing five 
phenotypes. Between one and five phenotype are simulated as a function of the genetic variant, where its 
proportion of variance explained was randomly chosen between 0.1% and 0.5%. The direction of the genetic 
effects was randomly chosen for each simulation and the associated phenotypes were randomly selected 
with equal probability. The bars represent the power of eight different tests. The univariate tests for each PC 
are shown in light grey and dark grey after correcting for the multiple testing, and the univariate test for the 
most significant PC (tPC) is in blue. The combined test of all five PCs is shown in black, and the univariate test 
for the corresponding Y in light green (dark green after correcting for the multiple testing). The power is 
shown for four different correlation models and 10,000 simulation replicates with 2000 individuals. 
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Figure S2. Power comparison for the multivariate analysis of five traits when pleiotropic effects depend on 
correlation. Power at 5 x 10-8 significance level for the detection of a genetic variant when analyzing five 
phenotypes. Between one and five phenotype are simulated as a function of the genetic variant, where its 
proportion of variance explained was randomly chosen between 0.1% and 0.5%. All genetic effects were 
positive and associated phenotypes were selected randomly with probability proportional to their level of 
correlation with other phenotype. The bars represent the power of eight different tests. The univariate tests 
for each PC are shown in light grey and dark grey after correcting for the multiple testing, and the univariate 
test for the most significant PC (tPC) is in blue. The combined test of all five PCs is shown in black, and the 
univariate test for the corresponding Y in light green (dark green after correcting for the multiple testing). The 
power is shown for four different correlation models and 10,000 simulation replicates with 2000 individuals. 
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Figure S3. Examples of simulation schemes. An illustrative example of the three hypothetical simulation 
schemes considered when generating a large number of correlated phenotypes. In model SC1 and SC2, the 
number of latent variable L is much smaller than the number of phenotypes M, while in model SC3, L is much 
larger than M. In model SC3, the phenotypes are grouped into clustered defined as function of sets of latent 
variables (red frame), although some latent variable can be associated with phenotype in different clusters. 
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Figure S4. Power comparison for the multivariate analysis of 100 traits: Plots from column A), B),C), and D) 
were simulated under simulation schemes SC1, SC1, SC2 and SC3 respectively (the schemes are describe in 
text S2 and figure S3). The top panel shows the power at 5 x 10-8 significance level for six different tests. The 
plain red curve corresponds to the test combining signal from the n PCs associated with the largest 
eigenvalues, the plain black curve corresponds to the test combining information on the 101-n PCs associated 
with the smallest eigenvalues, and the green curve correspond to the combined test of two previous tests 
using the Fisher’s method, with n varying from 1 to 100. The dashed grey line corresponds to the test of all 
PCs combined, the dashed orange line to MANOVA and the dashed purple line to the TATES method. The 
middle panel displays the distribution of pairwise phenotypic correlation and the bottom panel distribution of 
the proportion of variance explained by each PC ordered by eigenvalues when analyzing 100 phenotypes. 
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Figure S5. Power of alternative methods for the multivariate analysis of five traits. A comparison of the 
power (at 5 x 10-8 significance level) for detecting a genetic variant using a standard univariate test (green) 
and five different multiple trait analysis: most significant PC (tPC, in blue); the combined PCs (in black); 
Manova (MAN, in red); Multiphen (MUL, in orange); TATES (TATE, in purple).  These test were applied to five 
traits where the number of traits with causal genetic effect was varied between one and five.  The five traits 
were simulated under simulated under four different correlation models, each with 10,000 replicates and 
2000 individuals. The proportion of variance explained by the genetic variant explained was randomly chosen 
between 0.1% and 0.5%. All genetic effects were positive and associated phenotypes were selected randomly 
with probability proportional to their level of correlation with other phenotype. 
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Figure S6. QQplot of Multiphen, MANOVA and the combined PC approach under the null. : QQ-plots and 
the inflation factor (lambda) under the null hypothesis of no association between the tested genetic variant 
and any of the phenotype under study, when analyzing 10, 50 and 100 phenotypes in 1000, 2000 and 5000 
individuals among 10,000 replicates for Multiphen (left column), MANOVA (central column) and, the 
combined PCs approach (right column), when the correlations between phenotypes is following a gradient 
from 0 to 0.8.  
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Table S1. Correlation matrix between the five coagulation factors related phenotypes 
 
FVIII vWF aPTT ACVn FIB 
FVIII 1 0.758 -0.452 -0.333 0.243 
vWF 0.758 1 -0.290 -0.227 0.232 
aPTT -0.452 -0.290 1 0.245 -0.013 
ACVn -0.333 -0.227 0.245 1 -0.055 
FIB 0.243 0.232 -0.013 -0.055 1 
Abbreviations: FIB, Fibrinogen ; FVIII, factor VIII ; vWF, von Willebrand factor; aPTT, the activated partial thromboplastin time ;  and 
ACVn, the standardized Anticoagulant response to Agkistrodon contortrix venom. 
 
 
Table S2. Loadings and proportion of variance explained for each principal component 
Original phenotypes Principal components 
 PC1 PC2 PC3 PC4 PC5 
ACVn 0.248 -0.253 0.931 0.052 0.064 
FVIII -0.599 -0.107 0.092 -0.238 0.751 
vWF -0.561 -0.045 0.208 -0.488 -0.634 
FIB -0.279 0.834 0.281 0.384 -0.016 
aPTT 0.432 0.476 0.044 -0.745 0.172 
%var explained 0.462 0.189 0.183 0.125 0.041 
Abbreviations: FIB, Fibrinogen ; FVIII, factor VIII ; vWF, von Willebrand factor; aPTT, the activated partial thromboplastin time ; ACVn, 
the standardized Anticoagulant response to Agkistrodon contortrix venom ; %var explained, proportion of total phenotypic variance 
explained. 
 
 
Table S3. Genomic inflation factor () for the univariate and multivariate analysis 
Phenotype  
ACVn 1.0117 
FIB 0.9991 
FVII 0.9865 
aPTT 1.0644 
vWF 0.9865 
PC1 0.9907 
PC2 0.9958 
PC3 1.0009 
PC4 1.0065 
PC5 1.0056 
Combined PCs 0.9939 
Abbreviations: FIB, Fibrinogen ; FVIII, factor VIII ; vWF, von Willebrand factor; aPTT, the activated partial thromboplastin time ; ACVn, 
the standardized Anticoagulant response to Agkistrodon contortrix venom ; %var explained, proportion of total phenotypic variance 
explained. 
 
  
28 
 
Text S1 
The proportion of the total variance explained by PC1 and PC2, respectively s1 and s2, is defined as: 
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The proportion of variance of PC1 and PC2 explain by G, respectively vpc1 and vpc2 can be expressed as a the 
ratio of the genetic effect of G on the variance of PC1 and PC2, that we denoted 1 and 2, respectively, divided 
by the total variance of PC1 and PC2. 
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Text S2 
When simulating 100 phenotypes, we considered three different simulation schemes, SC1, SC2 and SC3, 
which are illustrated in figure S3. In model SC1 the correlation between phenotypes is a result of a limited 
number (30) of independent latent variables, each affecting 40 phenotypes on average and explaining 
altogether 30% of the total phenotypic variance. The genetic effect on the phenotypes was generated 
independently from the latent variables, accounting or not for the pairwise phenotypic correlation. In model 
SC2, the phenotypic correlation was generated in similar fashion as in model SC1, i.e. using the same latent 
variables; however the genetic variant was associated with some of these latent variables but not directly to 
the phenotypes. In model SC3, we considered a more complex model involving thousands of latent variables 
together explaining 90% of the total phenotypic variance, sub-groups of these latent variables affecting 
cluster of phenotypes. As for model SC2, the genetic variant was associated with some of the latent variables.  
 
More specifically, in model SC1, the nphe phenotypes were generated as follows:   √          √  
  √          , where y is a vector of phenotypic values for a given subject, g is a SNP and   the 
vector of proportion of variance explained by that SNP on the nphe phenotypes;  u is a vector of realization of 
nu independent latent variables            normally distributed with mean 0 and variance 1,  is a 
matrix of (positive) weights with nu rows and nphe columns that defines the contribution of each variable Ui  to 
the phenotypes, these weights are defined so that for each phenotype j,  ∑    
  
  
    ; c is a vector of nphe 
weights that defined the proportion of variance explained by each linear combination   
       ; and , the 
residual variance is a vector of nphe independent variables, normally distributed with mean 0 and variance 1. 
In model SC2 and SC3 the nphe phenotypes were generated as follows: √          √        . A 
sub-sample of the Ui  were generated as a function of a SNP G such that    √     √         , 
where i is the effect of SNP on the latent variable Ui , and ei, the residual, is normally distributed with mean 
0 and variance 1. 
 
The parameters c and  and  of the three models were defined empirically to obtain a similar distribution of 
pairwise phenotypic correlation and a similar distribution of proportion of variance explained by the PCs 
(figure S4). Since the three models were very different, it was difficult to generate a similar range of genetic 
effects on the phenotypes. However, this was of secondary importance as the aim of this experiment was not 
to compare the models but to compare the power of different methods for analyzing correlated traits. 
Regardless, with these constraints, the genetic effects simulated (either directly on the phenotypes or on the 
latent variables) were explaining a very small proportion of the total phenotypic variance (<0.05%). For 
example, in model SC1, the SNP was associated with 10 traits and the variance that it explained for each 
phenotype was drawn from a uniform distribution with minimum 0.1% and maximum 0.5%, so that the total 
phenotypic variance explain was on average 0.025%.  In model SC2, the SNP had a similar effect size on 3 
latent variables, so that the average contribution of the SNP was 0.007%. These parameter choices resulted 
in similar distributions of pairwise phenotypic correlations (see figure S4). 
 
 
